跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
迈凡妥 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Mavacamten Capsules
Approved
化学药品
Mavacamten Capsules
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD
🇨🇳 National Medical Products Administration
Approval Date
Apr 24, 2024
Approval ID
8ZleUWLFgp4
Company
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD
Type
化学药品
Approval Details
Approval Id
8ZleUWLFgp4
Approval Number
国药准字HJ20240015
Generic Name
玛伐凯泰胶囊
Generic Name En
Mavacamten Capsules
Trade Name
迈凡妥
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
15mg
Reg Date
2024-04-24
Expired Date
2029-04-23
Company Name
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD
Production Company Name
Patheon Inc
Company Detail Path
/organization/bristol-myers-squibb-australia-pty-ltd
Production Company Detail Path
/organization/patheon-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 24, 2024
Approval ID
8ZleUWLFgp4
Type
化学药品
Back to NMPA Approvals